π΅οΈ Selectis Health, Inc. ($GBCS)
SEC insider & ownership activity, last 12 months Β· CIK 727346 Β· every row links its SEC filing
Over the last 12 months insiders bought $42K with no open-market selling against it. Desmond Adam bought $28K through a 10b5-1 trading plan in 22 lots (FebβDec). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $42K (23 lots) Β· 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Desmond Adam | 22 | $28K | 0 | β | Dec 31, 2025 |
| Baller Lance | 1 | $14K | 0 | β | Dec 18, 2025 |
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 22, 2026 | filing β |
| Reg FD disclosure (7.01) | Jun 22, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jun 22, 2026 | filing β |
| Officer/director changes (5.02) | May 14, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing β |
| Acquisition or disposition (2.01) | May 1, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 1, 2026 | filing β |
| Officer/director changes (5.02) | Mar 30, 2026 | filing β |
| Officer/director changes (5.02) | Mar 12, 2026 | filing β |
| Material agreement (1.01) | Mar 5, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing β |
| Acquisition or disposition (2.01) | Jan 15, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jan 15, 2026 | filing β |
| Officer/director changes (5.02) | Jan 1, 2026 | filing β |
| New financial obligation (2.03) | Dec 30, 2025 | filing β |
| Material Modifications to Rights of Security Holders (3.03) | Dec 30, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Dec 30, 2025 | filing β |
| Material agreement (1.01) | Dec 5, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Dec 5, 2025 | filing β |